{
  "symbol": "EVGN",
  "company_name": "Evogene Ltd Ord",
  "ir_website": "https://evogene.com/investor-relations/",
  "structured_data": [
    {
      "section_name": "Financial Reports",
      "links": [
        {
          "title": "Q2 2024 Financial Results",
          "url": "https://evogene.com/investor-relations/financial-reports/#Q2-2024-Financial-Results",
          "content": "  * Toggle High Contrast\n\n\n\n[![Evogene](https://evogene.com/wp-content/uploads/2020/06/logo-white-tagline-white.png)](https://evogene.com) [![Evogene](https://evogene.com/wp-content/uploads/2020/05/evogene-logo-72-e1589968875591.png)](https://evogene.com)\n\nToggle navigation\n\n  * [Company](https://evogene.com/about-evogene/)\n  * [Technology](https://evogene.com/technology/)\n  * [AI Tech-Engines](#)\n    * [![](https://evogene.com/wp-content/uploads/2023/08/MicroBoost-AI-Logo-white-1.svg)](https://evogene.com/micro-boost/)\n    * [![](https://evogene.com/wp-content/uploads/2023/08/ChemPass-AI-Logo-white.svg)](https://evogene.com/chempass-ai/)\n    * [![](https://evogene.com/wp-content/uploads/2023/08/GeneRator-AI-Logo-white-1.svg)](https://evogene.com/generator-ai/)\n  * [Licensing & Collaboration](https://evogene.com/licensing-collaboration/)\n  * [ESG](https://evogene.com/evogene-esg/)\n    * [Environmental](https://evogene.com/environmental/)\n    * [Social](https://evogene.com/social/)\n    * [Governance](https://evogene.com/governance/)\n  * [News & Events](https://evogene.com/news-events/)\n  * [Investors](https://evogene.com/investor-relations/)\n  * [Careers](https://evogene.com/careers/)\n  * [Contact](#contact)\n\n\n\n# Financial Reports\n\n[ Back ](https://evogene.com/investor-relations/)\n\n## Financial Reports\n\n  * [![pdf](https://evogene.com/wp-content/themes/evogene/assets/img/file.png)Q3 2024 Consolidated Financial Statements ](https://evogene.com/wp-content/uploads/2024/11/Evogene_Q3_2024_Results_FINAL.pdf)\n  * [![pdf](https://evogene.com/wp-content/themes/evogene/assets/img/file.png)Operating and Financial Review and Prospects_as of_and for the six month ended June 30 2024](https://evogene.com/wp-content/uploads/2024/09/Operating-and-Financial-Review-and-Prospects_as-of_and-for-the-six-month-ended-June-30-2024.pdf)\n  * [![pdf](https://evogene.com/wp-content/themes/evogene/assets/img/file.png)Q2 2024 Consolidated Financial Statements ](https://evogene.com/wp-content/uploads/2024/08/Evogene_Q2_2024_Results_FINAL.pdf)\n  * [![pdf](https://evogene.com/wp-content/themes/evogene/assets/img/file.png)Q1 2024 Consolidated Financial Statements ](https://evogene.com/wp-content/uploads/2024/05/EVOGENE_Q1_2024_Results__FINAL.pdf)\n  * [![pdf](https://evogene.com/wp-content/themes/evogene/assets/img/file.png)2024 Annual General Meeting of Shareholders](https://evogene.com/wp-content/uploads/2024/05/1714546119_a2431353_organized.pdf)\n  * [![pdf](https://evogene.com/wp-content/themes/evogene/assets/img/file.png)Annual Report 2023 - 20-F](https://evogene.com/wp-content/uploads/2024/03/Evogene-Annual-report-2023-20-F.pdf)\n  * [![pdf](https://evogene.com/wp-content/themes/evogene/assets/img/file.png)Q4 and Full Year 2023 Consolidated Financial Statements](https://evogene.com/wp-content/uploads/2024/03/Evogene_Q4-2023-Consolidated-Financial-Statements.pdf)\n  * [![pdf](https://evogene.com/wp-content/themes/evogene/assets/img/file.png)Q3 2023 Consolidated Financial Statements](https://evogene.com/wp-content/uploads/2023/11/Evogene-Third-Quarter-2023-Financial-Results.pdf)\n  * [![pdf](https://evogene.com/wp-content/themes/evogene/assets/img/file.png)Interim Financial Statements and MD&A for the Six Months Ended June 30, 2023 ](https://evogene.com/wp-content/uploads/2023/10/6MFS-and-MDA-Accessible.pdf)\n  * [![pdf](https://evogene.com/wp-content/themes/evogene/assets/img/file.png)Q2 2023 Consolidated Financial Statements ](https://evogene.com/wp-content/uploads/2023/08/Q2-2023-PR_FINAL_6K.pdf)\n  * [![pdf](https://evogene.com/wp-content/themes/evogene/assets/img/file.png)Q1 2023 Consolidated Financial Statements ](https://evogene.com/wp-content/uploads/2023/05/Evogene_Q1_2023_Results_PR_FINAL_6K.pdf)\n  * [![pdf](https://evogene.com/wp-content/themes/evogene/assets/img/file.png)Annual report 2022 - 20-F](https://evogene.com/wp-content/uploads/2023/03/Annual-report-2022-20-F.pdf)\n  * [![pdf](https://evogene.com/wp-content/themes/evogene/assets/img/file.png)Q4 and Full Year 2022 Consolidated Financial Statements](https://evogene.com/wp-content/uploads/2023/03/Evogene-PR-Q4-2022-Results-FINAL.pdf)\n  * [![pdf](https://evogene.com/wp-content/themes/evogene/assets/img/file.png)Q3 2022 Consolidated Financial Statements](https://evogene.com/wp-content/uploads/2022/11/Evogene-Q3.2022.pdf)\n\n\n\n  * [![pdf](https://evogene.com/wp-content/themes/evogene/assets/img/file.png)Q2 2022 Consolidated Financial Statements ](https://evogene.com/wp-content/uploads/2022/08/Evogene-Q2.2022.pdf)\n  * [![pdf](https://evogene.com/wp-content/themes/evogene/assets/img/file.png)Q1 2022 Consolidated Financial Statements ](https://evogene.com/wp-content/uploads/2022/05/Evogene-Q1.2022.pdf)\n  * [![pdf](https://evogene.com/wp-content/themes/evogene/assets/img/file.png) Annual report 2021 - 20-F](https://evogene.com/wp-content/uploads/2022/04/Evogene-Annual-report-2021-20-F.pdf)\n  * [![pdf](https://evogene.com/wp-content/themes/evogene/assets/img/file.png)Q4 2021 Consolidated Financial Statements ](https://evogene.com/wp-content/uploads/2022/03/Evogene-PR-Q4-2021-FINAL.pdf)\n  * [![pdf](https://evogene.com/wp-content/themes/evogene/assets/img/file.png)Q3 2021 Consolidated Financial Statements ](https://evogene.com/wp-content/uploads/2021/11/Evogene-Q3.2021-.pdf)\n  * [![pdf](https://evogene.com/wp-content/themes/evogene/assets/img/file.png)Q2 2021 Consolidated Financial Statements ](https://evogene.com/wp-content/uploads/2021/11/Q2-Results-.pdf)\n  * [![pdf](https://evogene.com/wp-content/themes/evogene/assets/img/file.png)Q1 2021 Consolidated Financial Statements ](https://evogene.com/wp-content/uploads/2021/11/Q1-Results-.pdf)\n  * [![pdf](https://evogene.com/wp-content/themes/evogene/assets/img/file.png)Annual report 2020 - 20-F ](https://evogene.com/wp-content/uploads/2021/04/20f_isa-1.pdf)\n  * [![pdf](https://evogene.com/wp-content/themes/evogene/assets/img/file.png)Q3 2020 Consolidated Financial Statements ](https://evogene.com/wp-content/uploads/2020/11/Evogene-Q3-V1.pdf)\n  * [![pdf](https://evogene.com/wp-content/themes/evogene/assets/img/file.png)Q2 2020 Consolidated Financial Statements ](https://evogene.com/wp-content/uploads/2020/08/Evogene-30.06.2020-.pdf)\n  * [![pdf](https://evogene.com/wp-content/themes/evogene/assets/img/file.png)Q1 2020 Consolidated Financial Statements ](https://evogene.com/wp-content/uploads/2020/05/EVOGENE-FS-31.03.2020-.pdf)\n  * [![pdf](https://evogene.com/wp-content/themes/evogene/assets/img/file.png)Annual report 2019 - 20-F ](https://evogene.com/wp-content/uploads/2020/05/a2024279.pdf)\n  * [![pdf](https://evogene.com/wp-content/themes/evogene/assets/img/file.png)Q4 2019 Consolidated Financial Statements ](https://evogene.com/wp-content/uploads/2020/03/Evogene-6K-31.12.19.pdf)\n  * [![pdf](https://evogene.com/wp-content/themes/evogene/assets/img/file.png)Q3 2019 Consolidated Financial Statements](https://evogene.com/wp-content/uploads/2019/12/Evogene-Q3-FINAL.pdf)\n  * [![pdf](https://evogene.com/wp-content/themes/evogene/assets/img/file.png)Q2 2019 Consolidated Financial Statements](https://evogene.com/wp-content/uploads/2019/07/Evogene-30.06.2019.pdf)\n  * [![pdf](https://evogene.com/wp-content/themes/evogene/assets/img/file.png)Q1 2019 Consolidated Financial Statements](https://evogene.com/wp-content/uploads/2019/05/6K.-EVOGENE-FS-31.03.2019-.pdf)\n\n\n"
        }
      ]
    },
    {
      "section_name": "Press Releases",
      "links": [
        {
          "title": "Evogene Announces Positive Financial Impact from Recent Deals",
          "url": "https://evogene.com/investor-relations/press-releases/#recent-deals",
          "content": "  * Toggle High Contrast\n\n\n\n[![Evogene](https://evogene.com/wp-content/uploads/2020/06/logo-white-tagline-white.png)](https://evogene.com) [![Evogene](https://evogene.com/wp-content/uploads/2020/05/evogene-logo-72-e1589968875591.png)](https://evogene.com)\n\nToggle navigation\n\n  * [Company](https://evogene.com/about-evogene/)\n  * [Technology](https://evogene.com/technology/)\n  * [AI Tech-Engines](#)\n    * [![](https://evogene.com/wp-content/uploads/2023/08/MicroBoost-AI-Logo-white-1.svg)](https://evogene.com/micro-boost/)\n    * [![](https://evogene.com/wp-content/uploads/2023/08/ChemPass-AI-Logo-white.svg)](https://evogene.com/chempass-ai/)\n    * [![](https://evogene.com/wp-content/uploads/2023/08/GeneRator-AI-Logo-white-1.svg)](https://evogene.com/generator-ai/)\n  * [Licensing & Collaboration](https://evogene.com/licensing-collaboration/)\n  * [ESG](https://evogene.com/evogene-esg/)\n    * [Environmental](https://evogene.com/environmental/)\n    * [Social](https://evogene.com/social/)\n    * [Governance](https://evogene.com/governance/)\n  * [News & Events](https://evogene.com/news-events/)\n  * [Investors](https://evogene.com/investor-relations/)\n  * [Careers](https://evogene.com/careers/)\n  * [Contact](#contact)\n\n\n\n# Press releases\n\n[ Back ](https://evogene.com/investor-relations/)\n\n## Press releases\n\nJump to year 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024\n\n### [2024](#year_2024)\n\n#### Evogene Reports Third Quarter 2024 Financial Results\n\nNovember 21, 2024\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-third-quarter-2024-financial-results/)\n\n#### Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results\n\nNovember 19, 2024\n\n[Read full press release](https://evogene.com/press_release/lavie-bio-advances-its-bio-fungicide-lav321-targeting-downy-mildew-to-pre-commercial-stage-following-successful-2024-field-trial-results/)\n\n#### Lavie Bio Announces Commercial Expansion of Yalos® as Seed-Treatment for Soybean, Following Successful Field Trials\n\nNovember 12, 2024\n\n[Read full press release](https://evogene.com/press_release/lavie-bio-announces-commercial-expansion-of-yalos-as-seed-treatment-for-soybean-following-successful-field-trials/)\n\n#### Evogene Schedules Third Quarter 2024 Financial Results Release\n\nNovember 7, 2024\n\n[Read full press release](https://evogene.com/press_release/evogene-schedules-third-quarter-2024-financial-results-release/)\n\n#### Evogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule Design\n\nOctober 31, 2024\n\n[Read full press release](https://evogene.com/press_release/evogene-announces-collaboration-with-google-cloud-to-pioneer-generative-ai-foundation-model-for-novel-small-molecule-design/)\n\n#### Casterra Announces a Key Milestone in its Operational Expansion Plan in Africa, with Completion of First Shipment of Castor Seeds Grown and Processed in Kenya\n\nOctober 29, 2024\n\n[Read full press release](https://evogene.com/press_release/casterra-announces-a-key-milestone-in-its-operational-expansion-plan-in-africa-with-completion-of-first-shipment-of-castor-seeds-grown-and-processed-in-kenya/)\n\n#### Watershed AC, Evogene and Ben-Gurion University Receive Approval for Second Year Grant to Continue the Collaboration Focused on Improving Crustacean Traits Utilizing Gene Editing Technology\n\nOctober 8, 2024\n\n[Read full press release](https://evogene.com/press_release/watershed-ac-evogene-and-ben-gurion-university-receive-approval-for-second-year-grant-to-continue-the-collaboration-focused-on-improving-crustacean-traits-utilizing-gene-editing-technology/)\n\n#### Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of ‘MicroFermentor’, a Unique Technology that Can Change the Economics of Ag-Biologicals\n\nSeptember 30, 2024\n\n[Read full press release](https://evogene.com/press_release/lavie-bio-receives-grant-from-israel-innovation-authority-to-advance-the-development-of-microfermentor-a-unique-technology-that-can-change-the-economics-of-ag-biologicals/)\n\n#### Evogene Announces Pricing of US$5.5 Million Registered Direct Offering and Concurrent Private Placement\n\nAugust 23, 2024\n\n[Read full press release](https://evogene.com/press_release/evogene-announces-pricing-of-us5-5-million-registered-direct-offering-and-concurrent-private-placement/)\n\n#### Evogene Reports Second Quarter 2024 Financial Results\n\nAugust 22, 2024\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-second-quarter-2024-financial-results/)\n\n#### Evogene Schedules Second Quarter 2024 Financial Results Release\n\nAugust 12, 2024\n\n[Read full press release](https://evogene.com/press_release/evogene-schedules-second-quarter-2024-financial-results-release/)\n\n#### Evogene Regains Compliance with Nasdaq Minimum Closing Bid Price Rule\n\n[Read full press release](https://evogene.com/press_release/evogene-regains-compliance-with-nasdaq-minimum-closing-bid-price-rule-2/)\n\n#### Casterra Announces the Completion of a Successful Castor Seed Growing and Harvesting Season in Brazil\n\nJuly 31, 2024\n\n[Read full press release](https://evogene.com/press_release/casterra-announces-the-completion-of-a-successful-castor-seed-growing-and-harvesting-season-in-brazil/)\n\n#### Evogene Announces Expected Implementation of 1-for-10 Reverse Share Split\n\nJuly 23, 2024\n\n[Read full press release](https://evogene.com/press_release/evogene-announces-expected-implementation-of-1-for-10-reverse-share-split/)\n\n#### ICL and Lavie Bio Leverage Artificial Intelligence to Make Significant Advancement in Development of Yield Increasing Bio-Stimulants\n\nJuly 17, 2024\n\n[Read full press release](https://evogene.com/press_release/icl-and-lavie-bio-leverage-artificial-intelligence-to-make-significant-advancement-in-development-of-yield-increasing-bio-stimulants/)\n\n#### Lavie Bio Announces Commercial Expansion of Yalos™ to Winter Wheat\n\nJuly 2, 2024\n\n[Read full press release](https://evogene.com/press_release/lavie-bio-announces-commercial-expansion-of-yalos-to-winter-wheat/)\n\n#### Casterra Announces an Additional Purchase Order to Supply Castor Seeds to a New African Country\n\nJune 25, 2024\n\n[Read full press release](https://evogene.com/press_release/casterra-announces-an-additional-purchase-order-to-supply-castor-seeds-to-a-new-african-country/)\n\n#### Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & Melanoma\n\nMay 23, 2024\n\n[Read full press release](https://evogene.com/press_release/biomica-presents-positive-clinical-data-update-from-ongoing-phase-1-trial-of-microbiome-based-therapeutic-bmc128-for-refractory-rcc-nsclc-melanoma/)\n\n#### Evogene Reports First Quarter 2024 Financial Results\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-first-quarter-2024-financial-results/)\n\n#### Casterra Announces Additional Agreements with Seed Producers to Meet Existing & Growing Demand for its Elite Castor Seeds\n\nMay 21, 2024\n\n[Read full press release](https://evogene.com/press_release/casterra-announces-additional-agreements-with-seed-producers-to-meet-existing-growing-demand-for-its-elite-castor-seeds/)\n\n#### Evogene Schedules First Quarter 2024 Financial Results Release\n\nMay 9, 2024\n\n[Read full press release](https://evogene.com/press_release/evogene-schedules-first-quarter-2024-financial-results-release/)\n\n#### Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting\n\nApril 16, 2024\n\n[Read full press release](https://evogene.com/press_release/biomica-to-present-at-the-american-society-of-clinical-oncology-asco-2024-annual-meeting/)\n\n#### Biomica to Present at Digestive Disease Week (DDW) Conference 2024 Annual Meeting\n\nApril 11, 2024\n\n[Read full press release](https://evogene.com/press_release/biomica-to-present-at-digestive-disease-week-ddw-conference-2024-annual-meeting/)\n\n#### Evogene and The Kitchen FoodTech Hub by Strauss Group Established Finally Foods Ltd. – Revolutionizing Protein Production in Plants for the Food Industry\n\nApril 2, 2024\n\n[Read full press release](https://evogene.com/press_release/evogene-and-the-kitchen-foodtech-hub-by-strauss-group-established-finally-foods-ltd-revolutionizing-protein-production-in-plants-for-the-food-industry/)\n\n#### Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification\n\nMarch 20, 2024\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-receipt-of-nasdaq-minimum-bid-price-notification-2/)\n\n#### Bayer AG and Lavie Bio Continue for Second Year of Biofungicides Validation Following Successful Lab and Greenhouse Testing\n\nMarch 19, 2024\n\n[Read full press release](https://evogene.com/press_release/bayer-ag-and-lavie-bio-continue-for-second-year-of-biofungicides-validation-following-successful-lab-and-greenhouse-testing/)\n\n#### Lavie Bio and Ceres Global Ag Corp. Collaborate to Include YalosTM Bio-Inoculant, in Regenerative Agriculture Initiatives in North America\n\nMarch 13, 2024\n\n[Read full press release](https://evogene.com/press_release/lavie-bio-and-ceres-global-ag-corp-collaborate-to-include-yalostm-bio-inoculant-in-regenerative-agriculture-initiatives-in-north-america/)\n\n#### Evogene Reports Fourth Quarter and Full Year 2023 Financial Results\n\nMarch 7, 2024\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-fourth-quarter-and-full-year-2023-financial-results/)\n\n#### AgPlenus Achieves Milestone in Collaboration with Corteva to Develop Novel Herbicides\n\nMarch 6, 2024\n\n[Read full press release](https://evogene.com/press_release/agplenus-achieves-milestone-in-collaboration-with-corteva-to-develop-novel-herbicides/)\n\n#### Casterra Announces New Agreements with Seed Producers in Brazil and Africa to Meet Growing Demand for its Elite Castor Seed Varieties\n\nMarch 5, 2024\n\n[Read full press release](https://evogene.com/press_release/casterra-announces-new-agreements-with-seed-producers-in-brazil-and-africa-to-meet-growing-demand-for-its-elite-castor-seed-varieties/)\n\n#### Lavie Bio Successfully Secures Second Half Advance Payment of $2.5M after Meeting Corteva’s Licensing Agreement Requirements\n\nFebruary 28, 2024\n\n[Read full press release](https://evogene.com/press_release/lavie-bio-successfully-secures-second-half-advance-payment-of-2-5m-after-meeting-cortevas-licensing-agreement-requirements/)\n\n#### Evogene Schedules Fourth Quarter 2023 Financial Results Release & Conference Call for March 7th, 2024\n\nFebruary 26, 2024\n\n[Read full press release](https://evogene.com/press_release/evogene-schedules-fourth-quarter-2023-financial-results-release-conference-call-for-march-7th-2024/)\n\n#### AgPlenus Announces Appointment of Dr. Dan Jacob Gelvan as its Incoming Chief Executive Officer\n\nFebruary 22, 2024\n\n[Read full press release](https://evogene.com/press_release/agplenus-announces-appointment-of-dr-dan-jacob-gelvan-as-its-incoming-chief-executive-officer/)\n\n#### AgPlenus Announces Licensing & Collaboration Agreement with Bayer to Develop a New Sustainable Weed Control Solution\n\nFebruary 21, 2024\n\n[Read full press release](https://evogene.com/press_release/agplenus-announces-licensing-collaboration-agreement-with-bayer-to-develop-a-new-sustainable-weed-control-solution/)\n\n#### Syngenta and Lavie Bio Announce Partnership to Discover and Develop Novel Bio-Insecticide\n\nFebruary 20, 2024\n\n[Read full press release](https://evogene.com/press_release/syngenta-and-lavie-bio-announce-partnership-to-discover-and-develop-novel-bio-insecticide/)\n\n#### Evogene and Verb Biotics Enter Collaboration Agreement to Advance Probiotic Innovation\n\nFebruary 6, 2024\n\n[Read full press release](https://evogene.com/press_release/evogene-and-verb-biotics-enter-collaboration-agreement-to-advance-probiotic-innovation/)\n\n#### Biomica CEO Set to Engage in Panel Discussion at 8th Annual European Microbiome Movement Summit\n\nJanuary 23, 2024\n\n[Read full press release](https://evogene.com/press_release/biomica-ceo-set-to-engage-in-panel-discussion-at-8th-annual-european-microbiome-movement-summit/)\n\n#### Biomica Successfully Completes Phase I Trial Enrollment for Microbiome-Based Immuno-Oncology Drug\n\nJanuary 17, 2024\n\n[Read full press release](https://evogene.com/press_release/biomica-successfully-completes-phase-i-trial-enrollment-for-microbiome-based-immuno-oncology-drug/)\n\n### [2023](#year_2023)\n\n#### Biomica CEO Set to Attend JP Morgan Healthcare Week in San Francisco, January 8-11, 2024\n\nDecember 21, 2023\n\n[Read full press release](https://evogene.com/press_release/biomica-ceo-set-to-attend-jp-morgan-healthcare-week-in-san-francisco-january-8-11-2024/)\n\n#### Casterra Appoints New CEO and Expands Team to Drive Growth and Innovation\n\nDecember 19, 2023\n\n[Read full press release](https://evogene.com/press_release/casterra-appoints-new-ceo-and-expands-team-to-drive-growth-and-innovation/)\n\n#### Lavie Bio Announces a Distribution Agreement with WinField United Canada for its Bio-Inoculant Seed Treatment YalosTM\n\nDecember 5, 2023\n\n[Read full press release](https://evogene.com/press_release/lavie-bio-announces-a-distribution-agreement-with-winfield-united-canada-for-its-bio-inoculant-seed-treatment-yalostm/)\n\n#### Lavie Bio Announces Expansion of its Bio-Inoculant Product for Spring Wheat, Yalos™, to Durum and Barley\n\nNovember 28, 2023\n\n[Read full press release](https://evogene.com/press_release/lavie-bio-announces-expansion-of-its-bio-inoculant-product-for-spring-wheat-yalos-to-durum-and-barley/)\n\n#### Evogene Reports Third Quarter 2023 Financial Results\n\nNovember 15, 2023\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-third-quarter-2023-financial-results-2/)\n\n#### Lavie Bio Reports Advancement in Bio-Fungicide Program Against Downy Mildew with 2023 Field Trial Results\n\nNovember 8, 2023\n\n[Read full press release](https://evogene.com/press_release/lavie-bio-reports-advancement-in-bio-fungicide-program-against-downy-mildew-with-2023-field-trial-results/)\n\n#### Evogene Schedules Third Quarter 2023 Financial Results Release & Conference Call for November 15, 2023\n\nNovember 2, 2023\n\n[Read full press release](https://evogene.com/press_release/evogene-schedules-third-quarter-2023-financial-results-release-conference-call-for-november-15-2023/)\n\n#### Colors Farm, Evogene and Ben-Gurion University Collaborate to Establish Crustacean Gene Editing Technology\n\nOctober 31, 2023\n\n[Read full press release](https://evogene.com/press_release/colors-farm-evogene-and-ben-gurion-university-collaborate-to-establish-crustacean-gene-editing-technology/)\n\n#### Evogene Provides Operational Update Amidst Current Security Situation in Israel\n\nOctober 18, 2023\n\n[Read full press release](https://evogene.com/press_release/evogene-provides-operational-update-amidst-current-security-situation-in-israel/)\n\n#### Casterra Delivers First Shipment of Castor Seeds to Africa\n\nSeptember 27, 2023\n\n[Read full press release](https://evogene.com/press_release/casterra-delivers-first-shipment-of-castor-seeds-to-africa/)\n\n#### Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification\n\nSeptember 21, 2023\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-receipt-of-nasdaq-minimum-bid-price-notification/)\n\n#### Evogene Reports Second Quarter 2023 Financial Results\n\nAugust 17, 2023\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-second-quarter-2023-financial-results/)\n\n#### Biomica Opens Second Site to Advance Its Immuno-Oncology Drug Trials at Davidoff Center\n\nAugust 15, 2023\n\n[Read full press release](https://evogene.com/press_release/biomica-opens-second-site-to-advance-its-immuno-oncology-drug-trials-at-davidoff-center/)\n\n#### Evogene Schedules Second Quarter 2023 Financial Results Release & Conference Call for August 17, 2023\n\nJuly 31, 2023\n\n[Read full press release](https://evogene.com/press_release/evogene-schedules-second-quarter-2023-financial-results-release-conference-call-for-august-17-2023/)\n\n#### Evogene’s ChemPass AI Tech-Engine is Introduced with New Breakthrough Machine Learning Technology for Target-Protein Discovery\n\nJuly 25, 2023\n\n[Read full press release](https://evogene.com/press_release/evogenes-chempass-ai-tech-engine-is-introduced-with-new-breakthrough-machine-learning-technology-for-target-protein-discovery/)\n\n#### Biomica Announces Interim Positive Results from Pre-Clinical Studies in its Irritable Bowel Syndrome (IBS) Program\n\nJuly 19, 2023\n\n[Read full press release](https://evogene.com/press_release/biomica-announces-interim-positive-results-from-pre-clinical-studies-in-its-irritable-bowel-syndrome-ibs-program/)\n\n#### Evogene Announces Pricing of US$8,500,000 Registered Direct Offering\n\nJuly 17, 2023\n\n[Read full press release](https://evogene.com/press_release/evogene-announces-pricing-of-us8500000-registered-direct-offering/)\n\n#### Lavie Bio Announces Licensing Agreement for Bio-Fungicides with Corteva Agriscience\n\n[Read full press release](https://evogene.com/press_release/lavie-bio-announces-licensing-agreement-for-bio-fungicides-with-corteva-agriscience/)\n\n#### AgPlenus Appoints Dr. Adrian Percy to Its Board of Directors\n\nJuly 12, 2023\n\n[Read full press release](https://evogene.com/press_release/agplenus-appoints-dr-adrian-percy-to-its-board-of-directors/)\n\n#### Casterra Announces Additional $2.2 Million of Purchase Orders to Supply Castor Seeds for New African Territories\n\nJuly 3, 2023\n\n[Read full press release](https://evogene.com/press_release/casterra-announces-additional-2-2-million-of-purchase-orders-to-supply-castor-seeds-for-new-african-territories/)\n\n#### Casterra Signs a Framework Agreement with a World Leading Oil and Gas Company to Sell Its Castor Seeds for Sustainable Biofuel Production, with Initial Purchase Orders of $9.1 Million\n\nJune 21, 2023\n\n[Read full press release](https://evogene.com/press_release/casterra-signs-a-framework-agreement-with-a-world-leading-oil-and-gas-company-to-sell-its-castor-seeds-for-sustainable-biofuel-production-with-initial-purchase-orders-of-9-1-million/)\n\n#### Lavie Bio Receives Canadian Regulatory Approval for ThrivusTM, Expanding Global Reach\n\nMay 24, 2023\n\n[Read full press release](https://evogene.com/press_release/lavie-bio-receives-canadian-regulatory-approval-for-thrivustm-expanding-global-reach/)\n\n#### Evogene Reports First Quarter 2023 Financial Results\n\nMay 18, 2023\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-first-quarter-2023-financial-results/)\n\n#### Evogene Ag-Seed Division Awarded Prestigious €1.2M Horizon Grant to Develop Oil-Seed Crops with High CO2 Assimilation & Drought Tolerance\n\nMay 9, 2023\n\n[Read full press release](https://evogene.com/press_release/evogene-ag-seed-division-awarded-prestigious-e1-2m-horizon-grant-to-develop-oil-seed-crops-with-high-co2-assimilation-drought-tolerance/)\n\n#### Evogene Schedules First Quarter 2023 Financial Results Release & Conference Call for May 18, 2023\n\nMay 4, 2023\n\n[Read full press release](https://evogene.com/press_release/evogene-schedules-first-quarter-2023-financial-results-release-conference-call-for-may-18-2023/)\n\n#### Plantis Licenses Two of Canonic’s Proprietary Cannabis Varieties to Expand its Offerings in the Israeli Market\n\nMay 2, 2023\n\n[Read full press release](https://evogene.com/press_release/plantis-licenses-two-of-canonics-proprietary-cannabis-varieties-to-expand-its-offerings-in-the-israeli-market/)\n\n#### Biomica Announces Closing of $20 Million Financing Round led by Shanghai Healthcare Capital\n\nApril 27, 2023\n\n[Read full press release](https://evogene.com/press_release/biomica-announces-closing-of-20-million-financing-round-led-by-shanghai-healthcare-capital/)\n\n#### Evogene Announces Filing of Annual Report on Form 20-F\n\nMarch 30, 2023\n\n[Read full press release](https://evogene.com/press_release/evogene-announces-filing-of-annual-report-on-form-20-f/)\n\n#### Lavie Bio Announces Appointment of Amit Noam as its Incoming Chief Executive Officer\n\nMarch 29, 2023\n\n[Read full press release](https://evogene.com/press_release/lavie-bio-announces-appointment-of-amit-noam-as-its-incoming-chief-executive-officer/)\n\n#### Evogene Reports Fourth Quarter and Full Year 2022 Financial Results\n\nMarch 9, 2023\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-fourth-quarter-and-full-year-2022-financial-results/)\n\n#### Evogene to Attend the Annual ROTH Investor Conference in California on March 13, 2023\n\nMarch 1, 2023\n\n[Read full press release](https://evogene.com/press_release/evogene-to-attend-the-annual-roth-investor-conference-in-california-on-march-13-2023/)\n\n#### Lavie Bio Reports Successful Results for its Bio-Fungicides Programs\n\nFebruary 28, 2023\n\n[Read full press release](https://evogene.com/press_release/lavie-bio-reports-successful-results-for-its-bio-fungicides-programs/)\n\n#### Evogene Schedules Fourth Quarter and Full Year 2022 Financial Results Release & Conference Call for March 9, 2023\n\nFebruary 27, 2023\n\n[Read full press release](https://evogene.com/press_release/evogene-schedules-fourth-quarter-and-full-year-2022-financial-results-release-conference-call-for-march-9-2023/)\n\n#### Canonic Successfully Launched Six Second-Generation Cannabis Products with Higher THC and Rich Terpene Profiles\n\nFebruary 21, 2023\n\n[Read full press release](https://evogene.com/press_release/canonic-successfully-launched-six-second-generation-cannabis-products-with-higher-thc-and-rich-terpene-profiles/)\n\n#### Biomica CEO to Participate in Panel Discussion at 7th European Annual Microbiome Movement\n\nJanuary 24, 2023\n\n[Read full press release](https://evogene.com/press_release/biomica-ceo-to-participate-in-panel-discussion-at-7th-european-annual-microbiome-movement/)\n\n#### Casterra Announces Agreement with World Leading Energy Company to Cultivate its Castor Varieties at Commercial Scale\n\nJanuary 19, 2023\n\n[Read full press release](https://evogene.com/press_release/casterra-announces-agreement-with-world-leading-energy-company-to-cultivate-its-castor-varieties-at-commercial-scale/)\n\n### [2022](#year_2022)\n\n#### Biomica CEO to Attend the JP Morgan Healthcare Week in San Francisco between January 9-11, 2023\n\nDecember 28, 2022\n\n[Read full press release](https://evogene.com/press_release/biomica-ceo-to-attend-the-jp-morgan-healthcare-week-in-san-francisco-between-january-9-11-2023/)\n\n#### Biomica Raises $20 Million in a Financing Round to Advance its Pipeline of Microbiome-based Therapeutics\n\nDecember 21, 2022\n\n[Read full press release](https://evogene.com/press_release/biomica-raises-20-million-in-a-financing-round-to-advance-its-pipeline-of-microbiome-based-therapeutics/)\n\n#### Evogene to Receive $3.5 million Payment Related to Patent Portfolio under its Existing Seed Traits Collaboration with Bayer\n\nDecember 8, 2022\n\n[Read full press release](https://evogene.com/press_release/evogene-to-receive-3-5-million-payment-related-to-patent-portfolio-under-its-existing-seed-traits-collaboration-with-bayer/)\n\n#### Evogene Reports Third Quarter 2022 Financial Results\n\nNovember 17, 2022\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-third-quarter-2022-financial-results/)\n\n#### Casterra Signs Royalty Agreement with Titan for Castor Oil Sales in South-Eastern Africa\n\nNovember 15, 2022\n\n[Read full press release](https://evogene.com/press_release/casterra-signs-royalty-agreement-with-titan-for-castor-oil-sales-in-south-eastern-africa/)\n\n#### Biomica CEO to Participate in an Industry Panel Discussion at Microbiome Connect USA 2022 Summit\n\nNovember 14, 2022\n\n[Read full press release](https://evogene.com/press_release/biomica-ceo-to-participate-in-an-industry-panel-discussion-at-microbiome-connect-usa-2022-summit/)\n\n#### Evogene Schedules Third Quarter of 2022 Financial Results Release & Conference Call for November 17, 2022\n\nNovember 7, 2022\n\n[Read full press release](https://evogene.com/press_release/evogene-schedules-third-quarter-of-2022-financial-results-release-conference-call-for-november-17-2022/)\n\n#### Lavie Bio Advances its Novel Bio-fungicide Program and Applies to the U.S. EPA for Regulatory Approval\n\nOctober 12, 2022\n\n[Read full press release](https://evogene.com/press_release/lavie-bio-advances-its-novel-bio-fungicide-program-and-applies-to-the-u-s-epa-for-regulatory-approval/)\n\n#### Evogene to Present at the LD Micro Main Event XV Investor Conference in Los Angeles\n\nOctober 6, 2022\n\n[Read full press release](https://evogene.com/press_release/evogene-to-present-at-the-ld-micro-main-event-xv-investor-conference-in-los-angeles/)\n\n#### Canonic Launches its Second-Generation Medical Cannabis Products with High THC and Unique Terpene Profiles\n\nSeptember 21, 2022\n\n[Read full press release](https://evogene.com/press_release/canonic-launches-its-second-generation-medical-cannabis-products-with-high-thc-and-unique-terpene-profiles/)\n\n#### Lavie Bio Announces Appointment of Guri Oron as CEO\n\nSeptember 14, 2022\n\n[Read full press release](https://evogene.com/press_release/lavie-bio-announces-appointment-of-guri-oron-as-ceo/)\n\n#### Canonic Advances its Penetration into Europe by Signing its First Licensing Agreement with GroVida\n\nSeptember 13, 2022\n\n[Read full press release](https://evogene.com/press_release/canonic-advances-its-penetration-into-europe-by-signing-its-first-licensing-agreement-with-grovida/)\n\n#### Evogene to Present at the H.C. Wainwright 24th Annual Global Investment Conference\n\nSeptember 7, 2022\n\n[Read full press release](https://evogene.com/press_release/evogene-to-present-at-the-h-c-wainwright-24th-annual-global-investment-conference/)\n\n#### Evogene Reports Second Quarter 2022 Financial Results\n\nAugust 31, 2022\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-second-quarter-2022-financial-results/)\n\n#### Evogene Regains Compliance with Nasdaq Minimum Closing Bid Price Rule\n\nAugust 25, 2022\n\n[Read full press release](https://evogene.com/press_release/evogene-regains-compliance-with-nasdaq-minimum-closing-bid-price-rule/)\n\n#### ICL and Lavie Bio Enter Strategic Collaboration to Develop Novel Bio-Stimulant Products\n\nAugust 17, 2022\n\n[Read full press release](https://evogene.com/press_release/icl-and-lavie-bio-enter-strategic-collaboration-to-develop-novel-bio-stimulant-products/)\n\n#### Evogene Financial Results and Earnings Announcement Schedule for the Second Quarter of 2022\n\nAugust 2, 2022\n\n[Read full press release](https://evogene.com/press_release/evogene-financial-results-and-earnings-announcement-schedule-for-the-second-quarter-of-2022/)\n\n#### Biomica Announces First Patient Dosed in its Phase I Study of its Microbiome-Based Immuno-Oncology Drug\n\nJuly 26, 2022\n\n[Read full press release](https://evogene.com/press_release/biomica-announces-first-patient-dosed-in-its-phase-i-study-of-its-microbiome-based-immuno-oncology-drug/)\n\n#### Biomica Announces Successful Enrollment of First Patient in its Phase I Study of Microbiome-Based Immuno-Oncology Drug\n\nJuly 11, 2022\n\n[Read full press release](https://evogene.com/press_release/biomica-announces-successful-enrollment-of-first-patient-in-its-phase-i-study-of-microbiome-based-immuno-oncology-drug/)\n\n#### Biomica to Present at the Microbiome Connect Europe 2022\n\nJuly 5, 2022\n\n[Read full press release](https://evogene.com/press_release/biomica-to-present-at-the-microbiome-connect-europe-2022/)\n\n#### Biomica to Present at the 7th Microbiome Movement Drug Development Summit\n\nJune 15, 2022\n\n[Read full press release](https://evogene.com/press_release/biomica-to-present-at-the-7th-microbiome-movement-drug-development-summit/)\n\n#### Evogene Reports First Quarter 2022 Financial Results\n\nMay 26, 2022\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-first-quarter-2022-financial-results/)\n\n#### Biomica to Present at the ASCO 2022 Annual Meeting\n\nMay 23, 2022\n\n[Read full press release](https://evogene.com/press_release/biomica-to-present-at-the-asco-2022-annual-meeting/)\n\n#### Biomica to Present at the 2022 Digestive Disease Week (DDW) Conference\n\nMay 16, 2022\n\n[Read full press release](https://evogene.com/press_release/biomica-to-present-at-the-2022-digestive-disease-week-ddw-conference/)\n\n#### Lavie Bio Announces Successful Product Launch of its Bio-Inoculant result™ for the 2022 Spring Wheat Growing Season\n\nMay 11, 2022\n\n[Read full press release](https://evogene.com/press_release/lavie-bio-announces-successful-product-launch-of-its-bio-inoculant-result-for-the-2022-spring-wheat-growing-season/)\n\n#### Evogene Financial Results and Earnings Announcement Schedule for the First Quarter of 2022\n\nMay 10, 2022\n\n[Read full press release](https://evogene.com/press_release/evogene-financial-results-and-earnings-announcement-schedule-for-the-first-quarter-of-2022/)\n\n#### Biomica Announces Agreement with Sheba Medical Center for Joint Microbiome Clinical Research\n\nApril 13, 2022\n\n[Read full press release](https://evogene.com/press_release/biomica-announces-agreement-with-sheba-medical-center-for-joint-microbiome-clinical-research/)\n\n#### Evogene to Present at the Jefferies Virtual Synthetic Biology Week on March 23, 2022\n\nMarch 14, 2022\n\n[Read full press release](https://evogene.com/press_release/evogene-to-present-at-the-jefferies-virtual-synthetic-biology-week-on-march-23-2022/)\n\n#### Evogene Reports Fourth Quarter and Full Year 2021 Financial Results\n\nMarch 10, 2022\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-fourth-quarter-and-full-year-2021-financial-results/)\n\n#### Evogene to Attend to World Agri-Tech Innovation Summit from March 22-23, 2022\n\nMarch 7, 2022\n\n[Read full press release](https://evogene.com/press_release/evogene-to-attend-to-world-agri-tech-innovation-summit-from-march-22-23-2022/)\n\n#### Evogene to Attend the 34th Annual ROTH Investor Conference in Dana Point California Between March 13-15, 2022\n\nMarch 3, 2022\n\n[Read full press release](https://evogene.com/press_release/evogene-to-attend-the-34th-annual-roth-investor-conference-in-dana-point-california-between-march-13-15-2022/)\n\n#### Canonic Announces Professor Itamar Grotto Joining its Board of Directors\n\nFebruary 16, 2022\n\n[Read full press release](https://evogene.com/press_release/canonic-announces-professor-itamar-grotto-joining-its-board-of-directors/)\n\n#### Evogene Financial Results and Earnings Announcement Schedule for the Full Year and Fourth Quarter of 2021\n\nFebruary 15, 2022\n\n[Read full press release](https://evogene.com/press_release/evogene-financial-results-and-earnings-announcement-schedule-for-the-full-year-and-fourth-quarter-of-2021/)\n\n#### Evogene to Present at Aegis Virtual Conference\n\nFebruary 7, 2022\n\n[Read full press release](https://evogene.com/press_release/evogene-to-present-at-aegis-virtual-conference/)\n\n#### Canonic Announces Shipment of its Cannabis Varieties to Europe\n\nJanuary 31, 2022\n\n[Read full press release](https://evogene.com/press_release/canonic-announces-shipment-of-its-cannabis-varieties-to-europe/)\n\n#### Evogene to Participate in Edison Group’s Global Healthcare “Open House” Virtual Conference from January 25-27th, 2022\n\nJanuary 19, 2022\n\n[Read full press release](https://evogene.com/press_release/evogene-to-participate-in-edison-groups-global-healthcare-open-house-virtual-conference-from-january-25-27th-2022/)\n\n#### Canonic Announces Positive Results in Pre-Clinical Studies in its Precise Product Program for Medical Cannabis\n\nJanuary 18, 2022\n\n[Read full press release](https://evogene.com/press_release/canonic-announces-positive-results-in-pre-clinical-studies-in-its-precise-product-program-for-medical-cannabis/)\n\n#### Biomica Announces Clearance for First-in-Human Phase I Study of BMC-128 in Combination with Bristol Myers Squibb’s Anti-PD-1 Opdivo®\n\nJanuary 11, 2022\n\n[Read full press release](https://evogene.com/press_release/biomica-announces-clearance-for-first-in-human-phase-i-study-of-bmc-128-in-combination-with-bristol-myers-squibbs-anti-pd-1-opdivo/)\n\n### [2021](#year_2021)\n\n#### Lavie Bio Reports Advancement in its Bio-Fungicide Program for Fruit Rots\n\nDecember 14, 2021\n\n[Read full press release](https://evogene.com/press_release/lavie-bio-reports-advancement-in-its-bio-fungicide-program-for-fruit-rots/)\n\n#### Biomica Reports Positive Results from Pre-Clinical Studies in its Inflammatory Bowel Disease (IBD) Program\n\nNovember 30, 2021\n\n[Read full press release](https://evogene.com/press_release/biomica-reports-positive-results-from-pre-clinical-studies-in-its-inflammatory-bowel-disease-ibd-program/)\n\n#### Evogene Reports Third Quarter 2021 Financial Results\n\nNovember 17, 2021\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-third-quarter-2021-financial-results/)\n\n#### Evogene Announces Participation in the Second Research Period of the CRISPR-IL Consortium\n\nNovember 10, 2021\n\n[Read full press release](https://evogene.com/press_release/evogene-announces-participation-in-the-second-research-period-of-the-crispr-il-consortium/)\n\n#### Lavie Bio Announces Commercial Launch of its First Microbiome-Based Product for Yield Improvement – result™\n\nNovember 3, 2021\n\n[Read full press release](https://evogene.com/press_release/lavie-bio-announces-commercial-launch-of-its-first-microbiome-based-product-for-yield-improvement-result/)\n\n#### Biomica & Rambam Health Care Campus Sign Agreement for Clinical Trial of Biomica’s Microbiome-Based Immuno-Oncology Drug\n\nOctober 27, 2021\n\n[Read full press release](https://evogene.com/press_release/biomica-rambam-health-care-campus-sign-agreement-for-clinical-trial-of-biomicas-microbiome-based-immuno-oncology-drug/)\n\n#### Evogene Financial Results and Earnings Announcement Schedule for the Third Quarter of 2021\n\n[Read full press release](https://evogene.com/press_release/evogene-financial-results-and-earnings-announcement-schedule-for-the-third-quarter-of-2021/)\n\n#### Canonic Announces Full Commercial Launch of its First Medical Cannabis Products in Israel\n\nOctober 19, 2021\n\n[Read full press release](https://evogene.com/press_release/canonic-announces-full-commercial-launch-of-its-first-medical-cannabis-products-in-israel/)\n\n#### Lavie Bio and United Agronomy Announce Signing of Distribution Agreement for Lavie Bio’s Inoculant Product\n\nSeptember 29, 2021\n\n[Read full press release](https://evogene.com/press_release/lavie-bio-and-united-agronomy-announce-signing-of-distribution-agreement-for-lavie-bios-inoculant-product/)\n\n#### Evogene to Present at Cantor Virtual Global Healthcare Conference, September 2021\n\nSeptember 14, 2021\n\n[Read full press release](https://evogene.com/press_release/evogene-to-present-at-cantor-virtual-global-healthcare-conference-september-2021/)\n\n#### Evogene to Present at H.C. Wainwright 23rd Annual Global Investment Conference – 2021\n\nSeptember 1, 2021\n\n[Read full press release](https://evogene.com/press_release/evogene-to-present-at-h-c-wainwright-23rd-annual-global-investment-conference-2021/)\n\n#### Canonic Announces Pre-Launch of its First Generation Medical Cannabis Products in Israel\n\nAugust 31, 2021\n\n[Read full press release](https://evogene.com/press_release/canonic-announces-pre-launch-of-its-first-generation-medical-cannabis-products-in-israel/)\n\n#### Evogene Reports Second Quarter 2021 Financial Results\n\nAugust 11, 2021\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-second-quarter-2021-financial-results/)\n\n#### Evogene to Present at Jefferies Virtual Industrials Conference, 2021\n\nJuly 29, 2021\n\n[Read full press release](https://evogene.com/press_release/evogene-to-present-at-jefferies-virtual-industrials-conference-2021/)\n\n#### Evogene Financial Results and Earnings Announcement Schedule for the Second Quarter of 2021\n\nJuly 28, 2021\n\n[Read full press release](https://evogene.com/press_release/evogene-financial-results-and-earnings-announcement-schedule-for-the-second-quarter-of-2021/)\n\n#### AgPlenus Announces Positive Results for a Herbicide Resistance Trait to its Leading Herbicide Product Candidate\n\nJuly 6, 2021\n\n[Read full press release](https://evogene.com/press_release/agplenus-announces-positive-results-for-a-herbicide-resistance-trait-to-its-leading-herbicide-product-candidate/)\n\n#### Evogene Announces Ms. Sarit Firon to become Evogene’s Chairperson of the Board\n\nJune 23, 2021\n\n[Read full press release](https://evogene.com/press_release/evogene-announces-ms-sarit-firon-to-become-evogenes-chairperson-of-the-board/)\n\n#### Evogene Reports First Quarter 2021 Financial Results\n\nMay 26, 2021\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-first-quarter-2021-financial-results/)\n\n#### Lavie Bio Announces the Appointment of Russ Putland as Vice President Commercial\n\nMay 25, 2021\n\n[Read full press release](https://evogene.com/press_release/lavie-bio-announces-the-appointment-of-russ-putland-as-vice-president-commercial/)\n\n#### Evogene Financial Results and Earnings Announcement Schedule for the First Quarter of 2021\n\nMay 12, 2021\n\n[Read full press release](https://evogene.com/press_release/evogene-financial-results-and-earnings-announcement-schedule-for-the-first-quarter-of-2021/)\n\n#### Biomica To Present at Jefferies Microbiome-Based Therapeutics Summit, on April 22nd, 2021 (Virtual Conference)\n\nApril 19, 2021\n\n[Read full press release](https://evogene.com/press_release/biomica-to-present-at-jefferies-microbiome-based-therapeutics-summit-on-april-22nd-2021-virtual-conference/)\n\n#### Biomica Announces Positive Pre-Clinical Results, Demonstrating Efficacy of BMC128 in Melanoma\n\nApril 13, 2021\n\n[Read full press release](https://evogene.com/press_release/biomica-announces-positive-pre-clinical-results-demonstrating-efficacy-of-bmc128-in-melanoma/)\n\n#### Evogene to Hold Virtual Investor & Analyst Days\n\nApril 7, 2021\n\n[Read full press release](https://evogene.com/press_release/evogene-to-hold-virtual-investor-analyst-days/)\n\n#### Evogene Files Annual Report for the Year Ended December 31, 2020\n\nApril 2, 2021\n\n[Read full press release](https://evogene.com/press_release/evogene-files-annual-report-for-the-year-ended-december-31-2020/)\n\n#### Canonic of Evogene Group and Tikun Olam (Israel)-Cannbit, sign production and distribution agreements for Canonic products in Israel\n\nMarch 25, 2021\n\n[Read full press release](https://evogene.com/press_release/canonic-of-evogene-group-and-tikun-olam-israel-cannbit-sign-production-and-distribution-agreements-for-canonic-products-in-israel/)\n\n#### Plastomics and Evogene’s Ag-Seed division enter a collaborative agreement targeting novel insect control traits for soybean\n\nMarch 17, 2021\n\n[Read full press release](https://evogene.com/press_release/plastomics-and-evogenes-ag-seed-division-enter-a-collaborative-agreement-targeting-novel-insect-control-traits-for-soybean/)\n\n#### Evogene Reports Fourth Quarter and Full Year 2020 Financial Results\n\nMarch 3, 2021\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-fourth-quarter-and-full-year-2020-financial-results/)\n\n#### Cannbit, subsidiary of Tikun Olam-Cannbit, and Canonic of Evogene group announce collaboration for the development of novel medical cannabis products\n\nFebruary 24, 2021\n\n[Read full press release](https://evogene.com/press_release/cannbit-subsidiary-of-tikun-olam-cannbit-and-canonic-of-evogene-group-announce-collaboration-for-the-development-of-novel-medical-cannabis-products/)\n\n#### Evogene Financial Results and Earnings Announcement Schedule for the Fourth Quarter and Full Year of 2020\n\nFebruary 17, 2021\n\n[Read full press release](https://evogene.com/press_release/evogene-financial-results-and-earnings-announcement-schedule-for-the-fourth-quarter-and-full-year-of-2020/)\n\n#### Biomica Announces Participation at the Crohn’s & Colitis Congress® January 21-24, 2021 (Virtual Conference)\n\nJanuary 21, 2021\n\n[Read full press release](https://evogene.com/press_release/biomica-announces-participation-at-the-crohns-colitis-congress-january-21-24-2021-virtual-conference/)\n\n#### Biomica Announces Participation at the 5th Microbiome Movement Drug Development Europe Conference on January 28-29, 2021 (Virtual Conference)\n\nJanuary 20, 2021\n\n[Read full press release](https://evogene.com/press_release/biomica-announces-participation-at-the-5th-microbiome-movement-drug-development-europe-conference-on-january-28-29-2021-virtual-conference/)\n\n#### Evogene Provides 2020 Year-End Update for CRISPR-IL Consortium\n\nJanuary 5, 2021\n\n[Read full press release](https://evogene.com/press_release/evogene-provides-2020-year-end-update-for-crispr-il-consortium/)\n\n### [2020](#year_2020)\n\n#### Lavie Bio Provides Product Pipeline Update for 2020\n\nDecember 29, 2020\n\n[Read full press release](https://evogene.com/press_release/lavie-bio-provides-product-pipeline-update-for-2020/)\n\n#### Canonic Announces Signing of First Cultivation Agreement for its Medical Cannabis Varieties\n\nDecember 23, 2020\n\n[Read full press release](https://evogene.com/press_release/canonic-announces-signing-of-first-cultivation-agreement-for-its-medical-cannabis-varieties/)\n\n#### AgPlenus Announces Reaching a ‘Lead’ Stage in its Novel Mode-of-Action Herbicide Program\n\nDecember 15, 2020\n\n[Read full press release](https://evogene.com/press_release/agplenus-announces-reaching-a-lead-stage-in-its-novel-mode-of-action-herbicide-program/)\n\n#### Evogene Reports Third Quarter 2020 Financial Results\n\nNovember 18, 2020\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-third-quarter-2020-financial-results/)\n\n#### Canonic Received Approval for Propagation of Medical Cannabis from the Israel Medical Cannabis Agency\n\nNovember 11, 2020\n\n[Read full press release](https://evogene.com/press_release/canonic-received-approval-for-propagation-of-medical-cannabis-from-the-israel-medical-cannabis-agency/)\n\n#### Evogene Announces Closing of $12 Million Registered Direct Offering\n\nNovember 4, 2020\n\n[Read full press release](https://evogene.com/press_release/evogene-announces-closing-of-12-million-registered-direct-offering/)\n\n#### Evogene Financial Results and Earnings Announcement Schedule for the Third Quarter of 2020\n\nNovember 2, 2020\n\n[Read full press release](https://evogene.com/press_release/evogene-financial-results-and-earnings-announcement-schedule-for-the-third-quarter-of-2020/)\n\n#### Evogene Prices $12 Million Registered Direct Offering\n\nOctober 30, 2020\n\n[Read full press release](https://evogene.com/press_release/evogene-prices-12-million-registered-direct-offering/)\n\n#### Lavie Bio Announces Positive Results for LAV311 and LAV312 in its Bio-Fungicide Program\n\nOctober 29, 2020\n\n[Read full press release](https://evogene.com/press_release/lavie-bio-announces-positive-results-for-lav311-and-lav312-in-its-bio-fungicide-program/)\n\n#### Biomica Announces Initiation of Large-Scale Production of Live Bacterial Product (LBP) Candidate Consortium in its Immuno-Oncology Program\n\nOctober 13, 2020\n\n[Read full press release](https://evogene.com/press_release/biomica-announces-initiation-of-large-scale-production-of-live-bacterial-product-lbp-candidate-consortium-in-its-immuno-oncology-program/)\n\n#### Biomica Announces Participation at the H.C. Wainwright 22nd Annual Global Investment Conference on September 14-16, 2020 (Virtual Conference)\n\nSeptember 9, 2020\n\n[Read full press release](https://evogene.com/press_release/biomica-announces-participation-at-the-h-c-wainwright-22nd-annual-global-investment-conference-on-september-14-16-2020-virtual-conference/)\n\n#### Evogene Announces Participation at the H.C. Wainwright 22nd Annual Global Investment Conference on September 14-16, 2020 (Virtual Conference)\n\n[Read full press release](https://evogene.com/press_release/evogene-announces-participation-at-the-h-c-wainwright-22nd-annual-global-investment-conference-on-september-14-16-2020-virtual-conference/)\n\n#### Biomica Announces Positive Pre-Clinical Results in its Immuno-Oncology Program\n\nSeptember 8, 2020\n\n[Read full press release](https://evogene.com/press_release/biomica-announces-positive-pre-clinical-results-in-its-immuno-oncology-program/)\n\n#### Evogene Announces $10 Million Equity Investment led by ARK Investment Management, LLC\n\nSeptember 1, 2020\n\n[Read full press release](https://evogene.com/press_release/evogene-announces-10-million-equity-investment-led-by-ark-investment-management-llc/)\n\n#### Evogene to Present at LD 500 Virtual Conference\n\nAugust 19, 2020\n\n[Read full press release](https://evogene.com/press_release/evogene-to-present-at-ld-500-virtual-conference/)\n\n#### Evogene Reports Second Quarter 2020 Financial Results\n\nAugust 5, 2020\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-second-quarter-2020-financial-results/)\n\n#### Evogene to Present at Jefferies Virtual 2020 Industrials Conference\n\nJuly 29, 2020\n\n[Read full press release](https://evogene.com/press_release/evogene-to-present-at-jefferies-virtual-2020-industrials-conference/)\n\n#### Evogene Financial Results and Earnings Announcement Schedule for the Second Quarter of 2020\n\nJuly 15, 2020\n\n[Read full press release](https://evogene.com/press_release/evogene-financial-results-and-earnings-announcement-schedule-for-the-second-quarter-of-2020/)\n\n#### Evogene to Participate in CRISPR-IL Consortium to Provide end-to-end Artificial Intelligence System for Genome-Editing\n\nJune 3, 2020\n\n[Read full press release](https://evogene.com/press_release/evogene-to-participate-in-crispr-il-consortium-to-provide-end-to-end-artificial-intelligence-system-for-genome-editing/)\n\n#### Evogene Reports First Quarter 2020 Financial Results\n\nMay 26, 2020\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-first-quarter-2020-financial-results/)\n\n#### Evogene Launches its New Branding to Reflect the Company’s Expanded Vision and New Business Model\n\nMay 20, 2020\n\n[Read full press release](https://evogene.com/press_release/evogene-launches-its-new-branding-to-reflect-the-companys-expanded-vision-and-new-business-model/)\n\n#### Evogene Financial Results and Earnings Announcement Schedule for the First Quarter of 2020\n\nMay 7, 2020\n\n[Read full press release](https://evogene.com/press_release/evogene-financial-results-and-earnings-announcement-schedule-for-the-first-quarter-of-2020/)\n\n#### מכתב לבעלי מניות\n\nMay 6, 2020\n\n[Read full press release](https://evogene.com/press_release/%d7%9e%d7%9b%d7%aa%d7%91-%d7%9c%d7%91%d7%a2%d7%9c%d7%99-%d7%9e%d7%a0%d7%99%d7%95%d7%aa/)\n\n#### Letter to Shareholders\n\n[Read full press release](https://evogene.com/press_release/ceo-letter-to-shareholders-2/)\n\n#### Evogene Files Annual Report for the Year Ended December 31, 2019\n\nApril 30, 2020\n\n[Read full press release](https://evogene.com/press_release/evogene-files-annual-report-for-the-year-ended-december-31-2019/)\n\n#### Corteva Agriscience and AgPlenus Announce Collaboration for the Development of Novel Herbicides\n\nMarch 25, 2020\n\n[Read full press release](https://evogene.com/press_release/corteva-agriscience-and-agplenus-announce-collaboration-for-the-development-of-novel-herbicides/)\n\n#### Evogene Reports Fourth Quarter and Full Year 2019 Financial Results\n\nMarch 4, 2020\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-fourth-quarter-and-full-year-2019-financial-results/)\n\n#### Evogene to Attend in Bank of America 2020 Global Agriculture and Materials Conference\n\nFebruary 25, 2020\n\n[Read full press release](https://evogene.com/press_release/evogene-to-attend-in-bank-of-america-2020-global-agriculture-and-materials-conference/)\n\n#### Evogene Financial Results for the Fourth Quarter and Full Year of 2019 Earnings Announcement Schedule\n\nFebruary 12, 2020\n\n[Read full press release](https://evogene.com/press_release/evogene-financial-results-for-the-fourth-quarter-and-full-year-of-2019-earnings-announcement-schedule/)\n\n#### Canonic Announces an Agreement with Hadassah Medical Center for Pre-Clinical Studies to Support the Development of Canonic’s Medical Cannabis Products\n\nJanuary 27, 2020\n\n[Read full press release](https://evogene.com/press_release/canonic-announces-an-agreement-with-hadassah-medical-center-for-pre-clinical-studies-to-support-the-development-of-canonics-medical-cannabis-products/)\n\n#### Biomica Enters New Agreement with Biose Industrie for Scale-up and GMP Production of Drug Candidates BMC121 & BMC127 for its Immuno-Oncology Program\n\nJanuary 13, 2020\n\n[Read full press release](https://evogene.com/press_release/biomica-enters-new-agreement-with-biose-industrie-for-scale-up-and-gmp-production-of-drug-candidates-bmc121-bmc127-for-its-immuno-oncology-program/)\n\n### [2019](#year_2019)\n\n#### Lavie Bio Announces Advancement in its Product Development Pipeline for Wheat Bio-Stimulants\n\nNovember 18, 2019\n\n[Read full press release](https://evogene.com/press_release/lavie-bio-announces-advancement-in-its-product-development-pipeline-for-wheat-bio-stimulants/)\n\n#### Evogene Reports Third Quarter 2019 Financial Results\n\nNovember 13, 2019\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-third-quarter-2019-financial-results/)\n\n#### Biomica Reports Positive Preliminary Results in Animal Studies in its Immuno-Oncology Program\n\nNovember 12, 2019\n\n[Read full press release](https://evogene.com/press_release/biomica-reports-positive-preliminary-results-in-animal-studies-in-its-immuno-oncology-program/)\n\n#### Canonic Announces Initiation of Cultivation and Breeding of Cannabis Varieties with Unique Genomic Profiles for the Development of Medical Cannabis Products\n\nNovember 6, 2019\n\n[Read full press release](https://evogene.com/press_release/canonic-announces-initiation-of-cultivation-and-breeding-of-cannabis-varieties-with-unique-genomic-profiles-for-the-development-of-medical-cannabis-products/)\n\n#### Biomica To Collaborate with Weizmann Institute of Science to Develop A Selective Treatment Against Antibiotic Resistant Bacteria\n\nOctober 23, 2019\n\n[Read full press release](https://evogene.com/press_release/biomica-to-collaborate-with-weizmann-institute-of-science-to-develop-a-selective-treatment-against-antibiotic-resistant-bacteria/)\n\n#### Evogene Financial Results for the Third Quarter of 2019 Earnings Announcement Schedule\n\n[Read full press release](https://evogene.com/press_release/evogene-financial-results-for-the-third-quarter-of-2019-earnings-announcement-schedule/)\n\n#### Biomica Announces Advancement to Pre-Clinical Studies in its Inflammatory Bowel Disease Program\n\nOctober 2, 2019\n\n[Read full press release](https://evogene.com/press_release/biomica-announces-advancement-to-pre-clinical-studies-in-its-inflammatory-bowel-disease-program/)\n\n#### Lavie Bio, Evogene’s Ag-Biologicals Subsidiary, Announces the Nomination of Industry Experts to its Board of Directors\n\nSeptember 11, 2019\n\n[Read full press release](https://evogene.com/press_release/lavie-bio-evogenes-ag-biologicals-subsidiary-announces-the-nomination-of-industry-experts-to-its-board-of-directors/)\n\n#### Canonic to Present at CannX, 4th International Medical Cannabis Conference in Tel Aviv\n\nSeptember 4, 2019\n\n[Read full press release](https://evogene.com/press_release/canonic-to-present-at-cannx-4th-international-medical-cannabis-conference-in-tel-aviv/)\n\n#### Corteva Agriscience to Invest in Evogene’s Agriculture Biologicals Subsidiary, Lavie Bio\n\nAugust 7, 2019\n\n[Read full press release](https://evogene.com/press_release/corteva-agriscience-to-invest-in-evogenes-agriculture-biologicals-subsidiary-lavie-bio/)\n\n#### Evogene Reports Second Quarter of 2019 Financial Results\n\nJuly 31, 2019\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-second-quarter-of-2019-financial-results/)\n\n#### Evogene Amends its Collaboration Agreement with Bayer to Include Genome Editing Targets\n\nJuly 16, 2019\n\n[Read full press release](https://evogene.com/press_release/evogene-amends-its-collaboration-agreement-with-bayer-to-include-genome-editing-targets/)\n\n#### Evogene to Present at Jefferies 2019 Industrials Conference\n\nJuly 15, 2019\n\n[Read full press release](https://evogene.com/press_release/evogene-to-present-at-jefferies-2019-industrials-conference/)\n\n#### Evogene Financial Results for the Second Quarter of 2019 Earnings Announcement Schedule\n\nJuly 11, 2019\n\n[Read full press release](https://evogene.com/press_release/evogene-financial-results-for-the-second-quarter-of-2019-earnings-announcement-schedule/)\n\n#### Lavie Bio Announces Positive 2nd Year Field Results in its Bio-Stimulant Program for Wheat\n\nJuly 10, 2019\n\n[Read full press release](https://evogene.com/press_release/lavie-bio-announces-positive-2nd-year-field-results-in-its-bio-stimulant-program-for-wheat/)\n\n#### Evogene Reports First Quarter of 2019 Financial Results\n\nMay 28, 2019\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-first-quarter-of-2019-financial-results/)\n\n#### Evofuel to participate in the 2019 International Castor Oil Association – ICOA Conference\n\nMay 21, 2019\n\n[Read full press release](https://evogene.com/press_release/evofuel-to-participate-in-the-2019-international-castor-oil-association-icoa-conference/)\n\n#### Evogene Financial Results for the First Quarter of 2019 Earnings Announcement Schedule\n\nMay 7, 2019\n\n[Read full press release](https://evogene.com/press_release/evogene-financial-results-for-the-first-quarter-of-2019-earnings-announcement-schedule/)\n\n#### Biomica Initiates Pre-Clinical Studies in its Immuno-Oncology Program\n\nApril 16, 2019\n\n[Read full press release](https://evogene.com/press_release/biomica-initiates-pre-clinical-studies-in-its-immuno-oncology-program/)\n\n#### Evogene to Develop Next Generation Medical Cannabis Products through New Subsidiary – Canonic Ltd\n\nApril 3, 2019\n\n[Read full press release](https://evogene.com/press_release/evogene-to-develop-next-generation-medical-cannabis-products-through-new-subsidiary-canonic-ltd/)\n\n#### AgPlenus – Evogene’s Ag-Chemicals Subsidiary – Announces the Nomination of Three Industry Leaders from the Field of Crop Protection to its Board of Directors\n\nMarch 14, 2019\n\n[Read full press release](https://evogene.com/press_release/agplenus-evogenes-ag-chemicals-subsidiary-announces-the-nomination-of-three-industry-leaders-from-the-field-of-crop-protection-to-its-board-of-directors/)\n\n#### Evogene to Participate in the World Agritech, Innovation Summit in San Francisco in March 19-20, 2019\n\n[Read full press release](https://evogene.com/press_release/evogene-to-participate-in-the-world-agritech-innovation-summit-in-san-francisco-in-march-19-20-2019/)\n\n#### Evogene Reports Fourth Quarter and Full Year 2018 Financial Results\n\nMarch 13, 2019\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-fourth-quarter-and-full-year-2018-financial-results/)\n\n#### Letter to Shareholders\n\n[Read full press release](https://evogene.com/press_release/letter-to-shareholders/)\n\n#### Evogene Fourth Quarter and Full Year of 2018 Earnings Announcement Schedule\n\nFebruary 28, 2019\n\n[Read full press release](https://evogene.com/press_release/evogene-fourth-quarter-and-full-year-of-2018-earnings-announcement-schedule/)\n\n#### Evogene Announces Establishment of Ag-Biologicals Subsidiary – LaVie Bio Ltd.\n\nFebruary 26, 2019\n\n[Read full press release](https://evogene.com/press_release/evogene-announces-establishment-of-ag-biologicals-subsidiary-lavie-bio-ltd/)\n\n#### Evogene Appoints Dr. Adrian Percy to its Board of Directors\n\nFebruary 4, 2019\n\n[Read full press release](https://evogene.com/press_release/evogene-appoints-dr-adrian-percy-to-its-board-of-directors/)\n\n### [2018](#year_2018)\n\n#### Evogene and TMG Announce Collaboration to Develop Nematode Resistant Soybean through Genome Editing\n\nDecember 18, 2018\n\n[Read full press release](https://evogene.com/press_release/evogene-and-tmg-announce-collaboration-to-develop-nematode-resistant-soybean-through-genome-editing/)\n\n#### Evogene’s Leading Insect Control Genes Demonstrate Effectiveness Against Insects with Resistance to Current Commercial Solutions\n\nNovember 27, 2018\n\n[Read full press release](https://evogene.com/press_release/evogenes-leading-insect-control-genes-demonstrate-effectiveness-against-insects-with-resistance-to-current-commercial-solutions/)\n\n#### AgPlenus, a subsidiary of Evogene, to Present at the 2nd Annual AgChem & Technology Europe Conference\n\nNovember 19, 2018\n\n[Read full press release](https://evogene.com/press_release/agplenus-subsidiary-evogene-present-2nd-annual-agchem-technology-europe-conference/)\n\n#### Evogene Announces Establishment of Ag-Chemicals Subsidiary – AgPlenus Ltd.\n\n[Read full press release](https://evogene.com/press_release/evogene-announces-establishment-ag-chemicals-subsidiary-agplenus-ltd/)\n\n#### Evogene Reports Third Quarter 2018 Financial Results\n\nNovember 14, 2018\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-third-quarter-2018-financial-results/)\n\n#### Biomica Announces the Addition of Internationally Renowned Experts in the Fields of Gastroenterology and the Human Microbiome to its Scientific Advisory Board\n\nNovember 6, 2018\n\n[Read full press release](https://evogene.com/press_release/biomica-announces-addition-internationally-renowned-experts-fields-gastroenterology-human-microbiome-scientific-advisory-board/)\n\n#### Evofuel and Fantini s.r.l Announce Breakthrough in Mechanical Harvesting for Castor Bean\n\nOctober 29, 2018\n\n[Read full press release](https://evogene.com/press_release/evofuel-fantini-s-r-l-announce-breakthrough-mechanical-harvesting-castor-bean/)\n\n#### Evogene Financial Results for the Third Quarter of 2018 Earnings Announcement Schedule\n\nOctober 24, 2018\n\n[Read full press release](https://evogene.com/press_release/evogene-financial-results-third-quarter-2018/)\n\n#### Evogene Announces a Significant Milestone in its Next Generation Herbicide Pipeline\n\nSeptember 5, 2018\n\n[Read full press release](https://evogene.com/press_release/evogene-announces-significant-milestone-next-generation-herbicide-pipeline/)\n\n#### Evogene Reports Second Quarter 2018 Financial Results\n\nAugust 8, 2018\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-second-quarter-2018-financial-results/)\n\n#### Evogene Financial Results for the Second Quarter of 2018 Earnings Announcement Schedule\n\nJuly 18, 2018\n\n[Read full press release](https://evogene.com/press_release/evogene-financial-results-second-quarter-2018-earnings-announcement-schedule/)\n\n#### Evogene and IMAmt Enter a Collaboration in the Field of Insect Resistance Traits in Cotton\n\nJuly 17, 2018\n\n[Read full press release](https://evogene.com/press_release/evogene-imamt-enter-collaboration-field-insect-resistance-traits-cotton/)\n\n#### Evogene Announces Positive Yield Results in its Bio-Stimulant Program for Wheat\n\nJuly 10, 2018\n\n[Read full press release](https://evogene.com/press_release/evogene-announces-positive-yield-results-bio-stimulant-program-wheat/)\n\n#### Evogene Reports First Quarter 2018 Financial Results\n\nMay 29, 2018\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-first-quarter-2018-financial-results/)\n\n#### BASF and Evogene announce multiyear collaboration for the development of novel insecticides\n\n[Read full press release](https://evogene.com/press_release/basf-evogene-announce-multiyear-collaboration-development-novel-insecticides/)\n\n#### Biomica Announces Participation in the Microbiome Invest Conference in London May 23, 2018\n\nMay 14, 2018\n\n[Read full press release](https://evogene.com/press_release/biomica-announces-participation-microbiome-invest-conference-london-may-23-2018/)\n\n#### Evogene Financial Results for the First Quarter of 2018 Earnings Announcement Schedule\n\nMay 10, 2018\n\n[Read full press release](https://evogene.com/press_release/evogene-financial-results-first-quarter-2018-earnings-announcement-schedule/)\n\n#### Evogene and Marrone Bio Innovations Announce Phase Advancement in their Insect Control Collaboration\n\nMay 8, 2018\n\n[Read full press release](https://evogene.com/press_release/evogene-marrone-bio-innovations-announce-phase-advancement-insect-control-collaboration/)\n\n#### Biomica, Evogene’s Newly Established Subsidiary, Announces Therapeutic Areas of Focus\n\nMay 1, 2018\n\n[Read full press release](https://evogene.com/press_release/biomica-evogenes-newly-established-subsidiary-announces-therapeutic-areas-focus/)\n\n#### Evogene Files Annual Report for the Year Ended December 31, 2017\n\nApril 1, 2018\n\n[Read full press release](https://evogene.com/press_release/evogene-files-annual-report-year-ended-december-31-2017/)\n\n#### Evogene Reports Fourth Quarter and Full Year 2017 Financial Results\n\nFebruary 28, 2018\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-fourth-quarter-full-year-2017-financial-results/)\n\n#### מכתב מנכ”ל אבוג’ן לבעלי המניות\n\n[Read full press release](https://evogene.com/press_release/%d7%9e%d7%9b%d7%aa%d7%91-%d7%9e%d7%a0%d7%9b%d7%9c-%d7%90%d7%91%d7%95%d7%92%d7%9f-%d7%9c%d7%91%d7%a2%d7%9c%d7%99-%d7%94%d7%9e%d7%a0%d7%99%d7%95%d7%aa/)\n\n#### CEO Letter to Shareholders\n\n[Read full press release](https://evogene.com/press_release/ceo-letter-to-shareholders/)\n\n#### Evogene Announces Positive Results in its Novel Mode-of-Action Herbicide Program\n\nFebruary 27, 2018\n\n[Read full press release](https://evogene.com/press_release/evogene-announces-positive-results-novel-mode-action-herbicide-program/)\n\n#### Evogene Financial Results for the Fourth Quarter and Full Year 2017 Earnings Announcement Schedule\n\nFebruary 12, 2018\n\n[Read full press release](https://evogene.com/press_release/evogene-financial-results-fourth-quarter-full-year-2017-earnings-announcement-schedule/)\n\n#### Evogene to Participate in Israeli Consortium to Develop Phenotyping Tools and Systems for Precision Agriculture\n\nJanuary 29, 2018\n\n[Read full press release](https://evogene.com/press_release/evogene-participate-israeli-consortium-develop-phenotyping-tools-systems-precision-agriculture/)\n\n#### Evogene Announces Positive 2nd Year Field Trial Results in Corn Bio-Stimulant Ag-Biologicals Program\n\nJanuary 10, 2018\n\n[Read full press release](https://evogene.com/press_release/evogene-announces-positive-2nd-year-field-trial-results-corn-bio-stimulant-ag-biologicals-program/)\n\n### [2017](#year_2017)\n\n#### Evogene Reports Third Quarter 2017 Financial Results\n\nNovember 22, 2017\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-third-quarter-2017-financial-results/)\n\n#### Evogene Financial Results for the Third Quarter of 2017 Earnings Announcement Schedule\n\nNovember 5, 2017\n\n[Read full press release](https://evogene.com/press_release/evogene-financial-results-third-quarter-2017-earnings-announcement-schedule/)\n\n#### Evogene Announces Revised and Expanded Market Focus and New Corporate Structure\n\nOctober 30, 2017\n\n[Read full press release](https://evogene.com/press_release/evogene-announces-revised-expanded-market-focus-new-corporate-structure/)\n\n#### Evogene & Rahan Meristem announce positive results in 2nd year field trials addressing Black Sigatoka disease in banana and the utilization of the results for genome editing\n\nSeptember 26, 2017\n\n[Read full press release](https://evogene.com/press_release/evogene-rahan-meristem-announce-positive-results-2nd-year-field-trials-addressing-black-sigatoka-disease-banana-utilization-results-genome-editing/)\n\n#### Evogene to Present at the 26th Asian-Pacific Weed Science Society Conference\n\nAugust 23, 2017\n\n[Read full press release](https://evogene.com/press_release/evogene-present-26th-asian-pacific-weed-science-society-conference/)\n\n#### Evogene Reports Second Quarter 2017 Financial Results\n\nAugust 10, 2017\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-second-quarter-2017-financial-results/)\n\n#### DuPont Pioneer & Evogene Announce Multiyear Research Collaboration for Development of Corn Bio-Stimulant Products\n\nJuly 26, 2017\n\n[Read full press release](https://evogene.com/press_release/dupont-pioneer-evogene-announce-multiyear-research-collaboration-development-corn-bio-stimulant-products/)\n\n#### Evogene Financial Results for the Second Quarter of 2017 Earnings Announcement Schedule\n\nJuly 20, 2017\n\n[Read full press release](https://evogene.com/press_release/evogene-financial-results-second-quarter-2017-earnings-announcement-schedule/)\n\n#### Evogene Achieves Important Milestone in Monsanto Crop Disease Collaboration\n\nJuly 11, 2017\n\n[Read full press release](https://evogene.com/press_release/evogene-achieves-important-milestone-monsanto-crop-disease-collaboration/)\n\n#### Evogene announces positive results in Insect Control Seed Trait Program and advancement to Phase-I of first toxin against Western corn rootworm\n\nJune 20, 2017\n\n[Read full press release](https://evogene.com/press_release/evogene-announces-positive-results-insect-control-seed-trait-program-advancement-phase-first-toxin-western-corn-rootworm/)\n\n#### Evogene Reports First Quarter 2017 Financial Results\n\nMay 17, 2017\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-first-quarter-2017-financial-results/)\n\n#### Evogene Financial Results for the First Quarter of 2017 Earnings Announcement Schedule\n\nApril 26, 2017\n\n[Read full press release](https://evogene.com/press_release/evogene-financial-results-first-quarter-2017-earnings-announcement-schedule/)\n\n#### Marrone Bio Innovations and Evogene Advance Novel Bacteria and Related Proteins Beyond Discovery into Insecticidal Product Development Phase\n\nMarch 28, 2017\n\n[Read full press release](https://evogene.com/press_release/marrone-bio-innovations-evogene-advance-novel-bacteria-related-proteins-beyond-discovery-insecticidal-product-development-phase/)\n\n#### Evogene to Present Innovative Approach for Improving Cannabis for Medical Needs at CannaTech Summit\n\nMarch 7, 2017\n\n[Read full press release](https://evogene.com/press_release/evogene-present-innovative-approach-improving-cannabis-medical-needs-cannatech-summit/)\n\n#### Evogene Reports Fourth Quarter and Full Year 2016 Financial Results\n\nFebruary 27, 2017\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-fourth-quarter-full-year-2016-financial-results/)\n\n#### Evogene and ICL Innovation Sign Collaboration for Development of Crop Enhancers\n\nFebruary 14, 2017\n\n[Read full press release](https://evogene.com/press_release/subscribe-rss-evogene-icl-innovation-sign-collaboration-development-crop-enhancers/)\n\n#### Evogene Fourth Quarter and Full Year 2016 Earnings Announcement Schedule\n\nFebruary 13, 2017\n\n[Read full press release](https://evogene.com/press_release/evogene-fourth-quarter-full-year-2016-earnings-announcement-schedule/)\n\n### [2016](#year_2016)\n\n#### Evogene to Transfer Stock Exchange Listing to Nasdaq\n\nDecember 20, 2016\n\n[Read full press release](https://evogene.com/press_release/evogene-transfer-stock-exchange-listing-nasdaq/)\n\n#### Evogene Reports Third Quarter 2016 Financial Results\n\nNovember 21, 2016\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-third-quarter-2016-financial-results/)\n\n#### Evogene Announces Positive Field Trial Results in Ag-biologicals Program\n\nNovember 16, 2016\n\n[Read full press release](https://evogene.com/press_release/evogene-announces-positive-field-trial-results-ag-biologicals-program/)\n\n#### Evogene Third Quarter 2016 Earnings Announcement Schedule\n\nNovember 2, 2016\n\n[Read full press release](https://evogene.com/press_release/evogene-third-quarter-2016-earnings-announcement-schedule/)\n\n#### Evogene and IMAmt Sign Collaboration for Genomic Promoter Discovery and Validation in Cotton\n\nOctober 19, 2016\n\n[Read full press release](https://evogene.com/press_release/evogene-imamt-sign-collaboration-genomic-promoter-discovery-validation-cotton/)\n\n#### Evogene Announces Joint Microbial Diversity Activity with University of Missouri\n\nSeptember 13, 2016\n\n[Read full press release](https://evogene.com/press_release/evogene-announces-joint-microbial-diversity-activity-university-missouri/)\n\n#### Evogene Announces Participation at the 18th Annual Rodman & Renshaw Global Investment Conference in New York City September 11-13th, 2016\n\nSeptember 1, 2016\n\n[Read full press release](https://evogene.com/press_release/evogene-announces-participation-18th-annual-rodman-renshaw-global-investment-conference-new-york-city-september-11-13th-2016/)\n\n#### Evogene Reports Second Quarter 2016 Financial Results\n\nAugust 11, 2016\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-second-quarter-2016-financial-results/)\n\n#### Evogene to Participate at Piper Jaffray Global Agriculture Symposium\n\nAugust 1, 2016\n\n[Read full press release](https://evogene.com/press_release/evogene-participate-piper-jaffray-global-agriculture-symposium/)\n\n#### Evogene Second Quarter 2016 Earnings Announcement Schedule\n\nJuly 25, 2016\n\n[Read full press release](https://evogene.com/press_release/evogene-second-quarter-2016-earnings-announcement-schedule/)\n\n#### Evogene Appoints a New Member to Board of Directors and a New Chief Operating Officer\n\nJuly 19, 2016\n\n[Read full press release](https://evogene.com/press_release/evogene-appoints-new-member-board-directors-new-chief-operating-officer/)\n\n#### Evogene to Present at Crops and Chemicals 2016 Conference\n\nJuly 13, 2016\n\n[Read full press release](https://evogene.com/press_release/evogene-present-crops-chemicals-2016-conference/)\n\n#### Evogene Reports Financial Results for the First Quarter of 2016\n\nMay 19, 2016\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-financial-results-first-quarter-2016/)\n\n#### Evogene and Marrone Bio Innovations Disclose Positive Results in Insect Control Collaboration\n\nMay 16, 2016\n\n[Read full press release](https://evogene.com/press_release/evogene-marrone-bio-innovations-disclose-positive-results-insect-control-collaboration/)\n\n#### Evogene to Present the Potential of Integrating Novel Genome Editing Technology with its Core Capabilities for Improved Seed Traits at Plant Genomics Congress\n\nMay 3, 2016\n\n[Read full press release](https://evogene.com/press_release/evogene-present-potential-integrating-novel-genome-editing-technology-core-capabilities-improved-seed-traits-plant-genomics-congress/)\n\n#### Evogene’s First Quarter 2016 Earnings Announcement Schedule\n\nMay 2, 2016\n\n[Read full press release](https://evogene.com/press_release/evogenes-first-quarter-2016-earnings-announcement-schedule/)\n\n#### Evogene Files Annual Report for the Year Ended December 31, 2015\n\nApril 25, 2016\n\n[Read full press release](https://evogene.com/press_release/evogene-files-annual-report-year-ended-december-31-2015/)\n\n#### Evogene Selected for Photosynthesis Research Consortium within European Horizon 2020 Program\n\nApril 19, 2016\n\n[Read full press release](https://evogene.com/press_release/evogene-selected-photosynthesis-research-consortium-within-european-horizon-2020-program/)\n\n#### Evogene Reports Fourth Quarter and Full Year 2015 Financial Results\n\nMarch 1, 2016\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-fourth-quarter-full-year-2015-financial-results/)\n\n#### Evogene Discloses Positive Results in Yield Improvement Collaboration with Monsanto Utilizing Novel ‘Trait-First’ Methodology\n\nFebruary 23, 2016\n\n[Read full press release](https://evogene.com/press_release/evogene-discloses-positive-results-yield-improvement-collaboration-monsanto-utilizing-novel-trait-first-methodology/)\n\n#### Evogenes Fourth Quarter with Full Year 2015 Earnings Announcement Schedule\n\nFebruary 9, 2016\n\n[Read full press release](https://evogene.com/press_release/evogenes-fourth-quarter-full-year-2015-earnings-announcement-schedule/)\n\n### [2015](#year_2015)\n\n#### Evogene Appoints Eyal Leibovitz as Chief Financial Officer\n\nDecember 22, 2015\n\n[Read full press release](https://evogene.com/press_release/evogene-appoints-eyal-leibovitz-chief-financial-officer/)\n\n#### BASF and Evogene Sign Collaboration Agreement for Novel Herbicide Discovery and Development\n\nDecember 8, 2015\n\n[Read full press release](https://evogene.com/press_release/basf-evogene-sign-collaboration-agreement-novel-herbicide-discovery-development/)\n\n#### Evogene Officially Opens Research and Development Facility in St. Louis, Missouri\n\nNovember 19, 2015\n\n[Read full press release](https://evogene.com/press_release/evogene-officially-opens-research-development-facility-st-louis-missouri/)\n\n#### Evogene Reports Third Quarter 2015 Financial Results\n\nNovember 18, 2015\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-third-quarter-2015-financial-results/)\n\n#### Evogene’s Third Quarter 2015 Earnings Announcement Schedule\n\nOctober 28, 2015\n\n[Read full press release](https://evogene.com/press_release/evogenes-third-quarter-2015-earnings-announcement-schedule/)\n\n#### Evogene to Present at Credit Suisse Annual Basic Materials Conference\n\nSeptember 16, 2015\n\n[Read full press release](https://evogene.com/press_release/evogene-present-credit-suisse-annual-basic-materials-conference/)\n\n#### Evogene to Establish Validation Capabilities for Soybean Cyst Nematodes\n\nAugust 17, 2015\n\n[Read full press release](https://evogene.com/press_release/evogene-establish-validation-capabilities-soybean-cyst-nematodes/)\n\n#### Evogene to Present at Jefferies 2015 Industrials Conference\n\nAugust 6, 2015\n\n[Read full press release](https://evogene.com/press_release/evogene-present-jefferies-2015-industrials-conference/)\n\n#### Evogene Reports Second Quarter 2015 Financial Results\n\nAugust 5, 2015\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-second-quarter-2015-financial-results/)\n\n#### Evogene Announces Successful Completion of First Computational Discovery of Novel Microbial Genes for Insect Control\n\nAugust 4, 2015\n\n[Read full press release](https://evogene.com/press_release/evogene-announces-successful-completion-first-computational-discovery-novel-microbial-genes-insect-control/)\n\n#### Evogene to Participate at Piper Jaffray Technology-Enabled Industrials Symposium\n\nAugust 3, 2015\n\n[Read full press release](https://evogene.com/press_release/evogene-participate-piper-jaffray-technology-enabled-industrials-symposium/)\n\n#### Evogene Announces Discovery and Validation of Novel Plant Targets for Herbicides\n\nJuly 29, 2015\n\n[Read full press release](https://evogene.com/press_release/evogene-announces-discovery-validation-novel-plant-targets-herbicides/)\n\n#### Evogene’s Second Quarter 2015 Earnings Announcement Schedule\n\nJuly 15, 2015\n\n[Read full press release](https://evogene.com/press_release/evogenes-second-quarter-2015-earnings-announcement-schedule/)\n\n#### Evogene to Present at LD Micro Invitational\n\nMay 28, 2015\n\n[Read full press release](https://evogene.com/press_release/evogene-present-ld-micro-invitational/)\n\n#### Evogene Reports First Quarter 2015 Financial Results\n\nMay 19, 2015\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-first-quarter-2015-financial-results/)\n\n#### Evogene Files Annual Report for the Year Ended December 31, 2014\n\nApril 30, 2015\n\n[Read full press release](https://evogene.com/press_release/evogene-files-annual-report-year-ended-december-31-2014/)\n\n#### Evogene’s First Quarter 2015 Earnings Announcement Schedule\n\nApril 28, 2015\n\n[Read full press release](https://evogene.com/press_release/evogenes-first-quarter-2015-earnings-announcement-schedule/)\n\n#### Evogene CEO Ofer Haviv and Marrone Bio Innovations CEO Pam Marrone to Participate in ‘Profiling Tomorrow’s Ag Solutions’ Panel Discussion at AgriVest 2015\n\nApril 27, 2015\n\n[Read full press release](https://evogene.com/press_release/evogene-ceo-ofer-haviv-marrone-bio-innovations-ceo-pam-marrone-participate-profiling-tomorrows-ag-solutions-panel-discussion-agrivest-2015/)\n\n#### Evogene Discloses First Collaboration with Leading Multinational Food Company for Improving Crop Productivity\n\nMarch 18, 2015\n\n[Read full press release](https://evogene.com/press_release/evogene-discloses-first-collaboration-leading-multinational-food-company-improving-crop-productivity/)\n\n#### Evogene Reports Fourth Quarter and Full Year 2014 Financial Results\n\nFebruary 26, 2015\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-fourth-quarter-full-year-2014-financial-results/)\n\n#### Evogene Introduces Biology Driven Ag-Chemical Discovery Platform\n\nFebruary 24, 2015\n\n[Read full press release](https://evogene.com/press_release/evogene-introduces-biology-driven-ag-chemical-discovery-platform/)\n\n#### Evofuel Expands Castor Activity in Brazil with Insolo\n\nFebruary 17, 2015\n\n[Read full press release](https://evogene.com/press_release/evofuel-expands-castor-activity-brazil-insolo/)\n\n#### Evogene to Establish Research and Development Facility in the United States\n\nFebruary 9, 2015\n\n[Read full press release](https://evogene.com/press_release/evogene-establish-research-development-facility-united-states/)\n\n#### Evogene’s Fourth Quarter and Full Year 2014 Earnings Announcement Schedule\n\nFebruary 5, 2015\n\n[Read full press release](https://evogene.com/press_release/evogenes-fourth-quarter-full-year-2014-earnings-announcement-schedule/)\n\n#### Evogene New Gene Optimization Program Being Incorporated into Yield & Environmental Stress Collaboration with Monsanto\n\nFebruary 4, 2015\n\n[Read full press release](https://evogene.com/press_release/evogene-new-gene-optimization-program-incorporated-yield-environmental-stress-collaboration-monsanto/)\n\n### [2014](#year_2014)\n\n#### CNH Industrial and Evogene Subsidiary Announce Ongoing Collaboration for the Development of a Mechanized Harvesting Solution for Castor Beans\n\nDecember 15, 2014\n\n[Read full press release](https://evogene.com/press_release/cnh-industrial-evogene-subsidiary-announce-ongoing-collaboration-development-mechanized-harvesting-solution-castor-beans/)\n\n#### Evogene Reports Third Quarter 2014 Financial Results\n\nNovember 10, 2014\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-third-quarter-2014-financial-results/)\n\n#### Evogene Announces Expansion of Crop Protection Activities\n\nOctober 29, 2014\n\n[Read full press release](https://evogene.com/press_release/evogene-announces-expansion-crop-protection-activities/)\n\n#### Evogene’s Third Quarter 2014 Earnings Announcement Schedule\n\nOctober 22, 2014\n\n[Read full press release](https://evogene.com/press_release/evogenes-third-quarter-2014-earnings-announcement-schedule/)\n\n#### Evogene Subsidiary and Embrapa to Cooperate on Advancing Castor Cultivation in Brazil\n\nOctober 20, 2014\n\n[Read full press release](https://evogene.com/press_release/evogene-subsidiary-embrapa-cooperate-advancing-castor-cultivation-brazil/)\n\n#### Evogene Reports Second Quarter 2014 Financial Results\n\nAugust 20, 2014\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-second-quarter-2014-financial-results/)\n\n#### Evogene to Present at Credit Suisse 2014 Basic Materials Conference\n\nAugust 19, 2014\n\n[Read full press release](https://evogene.com/press_release/evogene-present-credit-suisse-2014-basic-materials-conference/)\n\n#### Evogene to Present at Jefferies 2014 Global Industrials Conference\n\nAugust 4, 2014\n\n[Read full press release](https://evogene.com/press_release/evogene-present-jefferies-2014-global-industrials-conference/)\n\n#### Evogene’s Second Quarter 2014 Earnings Announcement Schedule\n\nJuly 30, 2014\n\n[Read full press release](https://evogene.com/press_release/evogenes-second-quarter-2014-earnings-announcement-schedule/)\n\n#### Evogene Announces Amendment to Bayer Wheat Agreement to Focus on Discovery of Novel Genomic Promoters\n\nJuly 24, 2014\n\n[Read full press release](https://evogene.com/press_release/evogene-announces-amendment-bayer-wheat-agreement-focus-discovery-novel-genomic-promoters/)\n\n#### Evogene and Marrone Bio Innovations Sign Multi-Year Collaborative Agreement\n\nJuly 22, 2014\n\n[Read full press release](https://evogene.com/press_release/evogene-marrone-bio-innovations-sign-multi-year-collaborative-agreement/)\n\n#### Evogene Reports First Quarter 2014 Financial Results\n\nMay 7, 2014\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-first-quarter-2014-financial-results/)\n\n#### Evogene Enters the Field of Insect Resistance\n\nApril 29, 2014\n\n[Read full press release](https://evogene.com/press_release/evogene-enters-field-insect-resistance/)\n\n#### Evogene’s First Quarter 2014 Earnings Announcement Schedule\n\nApril 17, 2014\n\n[Read full press release](https://evogene.com/press_release/evogenes-first-quarter-2014-earnings-announcement-schedule/)\n\n#### Evogene Announces Filing of 2013 Annual Report\n\nApril 8, 2014\n\n[Read full press release](https://evogene.com/press_release/evogene-announces-filing-2013-annual-report/)\n\n#### Evogene Subsidiary and SLC Agricola Sign Collaboration Agreement for Commercial Production of Castor Bean in Brazil\n\nMarch 25, 2014\n\n[Read full press release](https://evogene.com/press_release/evogene-subsidiary-slc-agricola-sign-collaboration-agreement-commercial-production-castor-bean-brazil/)\n\n#### Evogene Reports Fourth Quarter and Year-End 2013 Financial Results\n\nMarch 19, 2014\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-fourth-quarter-year-end-2013-financial-results/)\n\n#### Evogene Enhances Predictive Gene Stacking Capabilities\n\nMarch 6, 2014\n\n[Read full press release](https://evogene.com/press_release/evogene-enhances-predictive-gene-stacking-capabilities/)\n\n### [2013](#year_2013)\n\n#### Evogene Announces Closing of its Initial Public Offering in the United States and Full-Exercise of Over-Allotment Option\n\nNovember 26, 2013\n\n[Read full press release](https://evogene.com/press_release/evogene-announces-closing-initial-public-offering-united-states-full-exercise-allotment-option/)\n\n#### Evogene Prices Its Initial Public Offering in the United States\n\nNovember 21, 2013\n\n[Read full press release](https://evogene.com/press_release/evogene-prices-initial-public-offering-united-states/)\n\n#### Monsanto and Evogene Extend and Expand Collaboration for Crop Improvement\n\nOctober 28, 2013\n\n[Read full press release](https://evogene.com/press_release/monsanto-evogene-extend-expand-collaboration-crop-improvement/)\n\n#### Evogene Reports Third Quarter 2013 Financial Results\n\nOctober 24, 2013\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-third-quarter-2013-financial-results/)\n\n#### Evogene and DuPont Pioneer Expand Collaboration For Soybean Rust Resistance\n\nOctober 15, 2013\n\n[Read full press release](https://evogene.com/press_release/evogene-dupont-pioneer-expand-collaboration-soybean-rust-resistance/)\n\n#### Evogene Files Registration Statement for Proposed Initial Public Offering in the United States\n\nSeptember 24, 2013\n\n[Read full press release](https://evogene.com/press_release/evogene-files-registration-statement-proposed-initial-public-offering-united-states/)\n\n#### Syngenta and Evogene Extend Soybean Nematode Resistance Collaboration\n\nSeptember 23, 2013\n\n[Read full press release](https://evogene.com/press_release/syngenta-evogene-extend-soybean-nematode-resistance-collaboration/)\n\n#### Evogene Subsidiary Completes Three Years of Successful Field Trials for Improved Castor Seeds\n\nSeptember 16, 2013\n\n[Read full press release](https://evogene.com/press_release/evogene-subsidiary-completes-three-years-successful-field-trials-improved-castor-seeds/)\n\n#### Evogene Reports Second Quarter and First Half 2013 Financial Results\n\nAugust 19, 2013\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-second-quarter-first-half-2013-financial-results/)\n\n#### Evogene and Rahan Announce Successful Field Trial Results For Black Sigatoka Resistance in Bananas\n\nAugust 6, 2013\n\n[Read full press release](https://evogene.com/press_release/evogene-rahan-announce-successful-field-trial-results-black-sigatoka-resistance-bananas/)\n\n#### Evogene Appoints Two New Members to Board of Directors\n\nJuly 22, 2013\n\n[Read full press release](https://evogene.com/press_release/evogene-appoints-two-new-members-board-directors/)\n\n#### Evogene Hosts President of the State of Israel, Mr. Shimon Peres\n\nJuly 15, 2013\n\n[Read full press release](https://evogene.com/press_release/evogene-hosts-president-state-israel-mr-shimon-peres/)\n\n#### Evogene to Collaborate with Chinese Biotechnology Company DBN on Improving Key Rice Traits\n\nMay 29, 2013\n\n[Read full press release](https://evogene.com/press_release/evogene-collaborate-chinese-biotechnology-company-dbn-improving-key-rice-traits/)\n\n#### Evogene Reports First Quarter 2013 Financial Results\n\nMay 13, 2013\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-first-quarter-2013-financial-results/)\n\n#### Evogene Announces Appointment of Chief Financial Officer\n\nMay 1, 2013\n\n[Read full press release](https://evogene.com/press_release/evogene-announces-appointment-chief-financial-officer/)\n\n#### Evogene Reports Fourth Quarter and Year End 2012 Financial Results\n\nMarch 24, 2013\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-fourth-quarter-year-end-2012-financial-results/)\n\n#### Evogene Announces Launch of Model Plant Validation System for Monocot Plants\n\nFebruary 12, 2013\n\n[Read full press release](https://evogene.com/press_release/evogene-announces-launch-model-plant-validation-system-monocot-plants/)\n\n#### Evogene Announces Launch of Gene2Product™ Computational AgBio Platform\n\nJanuary 29, 2013\n\n[Read full press release](https://evogene.com/press_release/evogene-announces-launch-gene2product-computational-agbio-platform/)\n\n### [2012](#year_2012)\n\n#### Evogene Reports First Quarter 2012 Financial Results\n\nMay 15, 2012\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-first-quarter-2012-financial-results/)\n\n#### Evogene Announces Launch of ATHLETE™ 4.0 Gene Discovery Computational Technology\n\nApril 4, 2012\n\n[Read full press release](https://evogene.com/press_release/evogene-announces-launch-athlete-4-0-gene-discovery-computational-technology/)\n\n#### Evogene Expands Research and Development Facilities by Over 50%\n\nApril 2, 2012\n\n[Read full press release](https://evogene.com/press_release/evogene-expands-research-development-facilities-50/)\n\n#### Evogene Reports Fourth Quarter and Year End 2011 Financial Results\n\nMarch 20, 2012\n\n[Read full press release](https://evogene.com/press_release/evogene-reports-fourth-quarter-year-end-2011-financial-results/)\n\n#### Evogene’s New Recruitments Expand Its Scientific Team\n\nJanuary 10, 2012\n\n[Read full press release](https://evogene.com/press_release/evogenes-new-recruitments-expand-scientific-team/)\n\n#### Evogene to Establish Evofuel Ltd. for Developing Advanced Feedstock for Biofuel\n\nJanuary 2, 2012\n\n[Read full press release](https://evogene.com/press_release/evogene-establish-evofuel-ltd-developing-advanced-feedstock-biofuel/)\n"
        }
      ]
    }
  ]
}